Integrating New Technology into Blood Plasma Fractionation

Curling,John;

Publication

Article

September 15, 2002

BioPharm International

BioPharm International-09-01-2002

Volume15

Issue 9

Integrating New Technology into Blood Plasma Fractionation

Author(s):

John Curling

by John Curling, ProMetic BioSciences Ltd. Immune serum globulin is in high demand, and that demand will only increase. Yet despite product shortages, the complexities involved in creating new manufacturing processes discourage change. The benefits - increased yield, reduced costs, new technologies, and faster throughput - now make identifying the best place in the processing stream to make manufacturing changes a rewrding endeavor. Planned change always trumps losing market share or being forced to change by new regulations.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Retrovirus and Parvovirus Clearance from an Affinity Column Product Using Adsorptive Depth Filtration

Reexamining the Set It and Forget It Approach

Controlled Clean Environment Enclosures: A Cost-Effective Alternative to Cleanrooms

Security in the Corporate Homeland

Integrating New Technology into Blood Plasma Fractionation

Attack Mounts on Pharmaceutical Prices

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Integrating New Technology into Blood Plasma Fractionation

Newsletter